1. Home
  2. PBK vs FEMY Comparison

PBK vs FEMY Comparison

Compare PBK & FEMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PowerBank Corporation Common Stock

PBK

PowerBank Corporation Common Stock

N/A

Current Price

$0.28

Market Cap

24.3M

Sector

Utilities

ML Signal

N/A

FEMY

Femasys Inc.

N/A

Current Price

$2.16

Market Cap

22.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PBK
FEMY
Founded
2013
2004
Country
Canada
United States
Employees
N/A
N/A
Industry
Power Generation
Medical/Dental Instruments
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.3M
22.4M
IPO Year
2024
2021

Fundamental Metrics

Financial Performance
Metric
PBK
FEMY
Price
$0.28
$2.16
Analyst Decision
Strong Buy
Buy
Analyst Count
2
3
Target Price
$4.00
★ $14.33
AVG Volume (30 Days)
★ 672.6K
67.0K
Earning Date
09-28-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 44.71
EPS
★ N/A
N/A
Revenue
N/A
★ $2,293,313.00
Revenue This Year
$171.32
N/A
Revenue Next Year
$40.20
$328.45
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 40.77
52 Week Low
$0.26
$0.29
52 Week High
$0.86
$6.29

Technical Indicators

Market Signals
Indicator
PBK
FEMY
Relative Strength Index (RSI) 31.10 37.40
Support Level $0.26 $0.41
Resistance Level $0.50 $3.21
Average True Range (ATR) 0.02 0.17
MACD 0.01 -0.04
Stochastic Oscillator 11.31 27.12

Price Performance

Historical Comparison
PBK
FEMY

About PBK PowerBank Corporation Common Stock

PowerBank Corp is an independent renewable and clean energy project developer, power producer, and asset operator in Canada and the United States, with the majority of its revenue coming from the United States. The Company operates through two reportable segments: Development and EPC, which involves the development and construction of solar photovoltaic power projects, and IPP Production, which includes the operation of solar power and battery energy storage systems. Corporate and other activities cover operation, maintenance, and repairs. The majority of revenue is generated from the Development and EPC segment.

About FEMY Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

Share on Social Networks: